Dilaudid Related Published Studies
Well-designed clinical trials related to Dilaudid (Hydromorphone)
Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain. [2009.10]
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. [2009.08]
Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. [2009.02]
A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain. [2008.10.31]
The side effects of morphine and hydromorphone patient-controlled analgesia. [2008.10]
Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. [2008.07]
Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study. [2008.07]
Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline. [2008.03.19]
Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. [2008.03]
Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. [2008.01]
Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. [2008.01]
Metoclopramide Versus Hydromorphone for the Emergency Department Treatment of Migraine Headache. [2007.11.02]
A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. [2007.06]
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. [2007.05]
Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. [2007.03]
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone. [2007.02.02]
Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial. [2006.08]
Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials. [2005.06]
Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules. [2005.05]
A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. [2004.04]
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis. [2004.01]
A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. [2003.09]
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers. [2003.07]
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. [2002.10]
The addition of hydromorphone to epidural fentanyl does not affect analgesia in early labour. [2002.06]
[Postoperative pain therapy with hydromorphone and metamizole. A prospective randomized study in intravenous patient-controlled analgesia (PCA)] [2001.10]
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. [2001.09]
Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. [2001.04.01]
Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. [2001.02]
Pharmacodynamics of orally administered sustained- release hydromorphone in humans. [2001.01]
Effect of pre-emptive hydromorphone administration on postoperative pain relief--a randomized controlled trial. [2000.12.07]
Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. [2000.09]
Comparison of subcutaneous hydromorphone with intramuscular meperidine for immediate postoperative analgesia. [1999.07]
Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial. [1999.07]
Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery. [1999]
Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. [1997.09]
Patient-controlled epidural analgesia: interactions between nalbuphine and hydromorphone. [1997.04]
Effects of ketorolac versus bupivacaine coadministration during patient-controlled hydromorphone epidural analgesia after thoracotomy procedures. [1997.03]
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. [1996.11]
Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. [1996.11]
Epidural morphine vs hydromorphone in post-caesarean section patients. [1996.06]
A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. [1996.05]
A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. [1996.05]
Pain outcomes after thoracotomy: lumbar epidural hydromorphone versus intrapleural bupivacaine. [1995.10]
Intravenous versus epidural administration of hydromorphone. Effects on analgesia and recovery after radical retropubic prostatectomy. [1995.03]
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. [1995.01]
Comparison of hydromorphone and meperidine for ureteral colic. [1994.11]
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. [1994.09.15]
Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. [1994.04]
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. [1994.04]
Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery. [1994.03]
Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study. [1993.04]
Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison. [1992.12]
Epidural patient-controlled analgesia: influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean delivery. [1992.11]
CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration. [1991.04]
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. [1991.02.23]
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. [1990.04]
Epidural hydromorphone with and without epinephrine for post-operative analgesia after cesarean delivery. [1989.03]
Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. [1988.09.21]
Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects. [1988.03]
Well-designed clinical trials possibly related to Dilaudid (Hydromorphone)
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply. [2009.09.01]
Epidural analgesia compared with intravenous analgesia after pediatric posterior spinal fusion. [2009.09]
Diacetylmorphine versus methadone for the treatment of opioid addiction. [2009.08.20]
Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study. [2009.06]
Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers. [2009.04.01]
The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. [2009.04]
The pain quality response profile of oxymorphone extended release in the treatment of low back pain. [2009.02]
Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. [2009.02]
Continuous lumbar plexus block for postoperative pain control after total hip arthroplasty. A randomized controlled trial. [2009.01]
Brain dopamine response in human opioid addiction. [2008.07]
Effect of orally administered tramadol alone or with an intravenously administered opioid on minimum alveolar concentration of sevoflurane in cats. [2008.06.15]
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. [2008.05]
The use of dexamethasone to reduce pain after tonsillectomy in adults: a double-blind prospective randomized trial. [2008.02]
Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. [2008.02]
Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. [2008.01]
Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department. [2007.12]
The Use of Dexamethasone to Reduce Pain After Tonsillectomy in Adults: A Double-Blind Prospective Randomized Trial. [2007.11.26]
Randomized trial comparing 3 methods of postoperative analgesia in gynecology patients: patient-controlled intravenous, scheduled intravenous, and scheduled subcutaneous. [2007.11]
Mapping MOS Sleep Scale scores to SF-6D utility index. [2007.09]
Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. [2007.06]
The effects of surgery and anesthesia on blood magnesium and calcium concentrations in canine and feline patients. [2007.03]
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. [2007.01.01]
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [2007.01]
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. [2006.12]
The effect of nitrous oxide on halothane, isoflurane and sevoflurane requirements in ventilated dogs undergoing ovariohysterectomy. [2006.11]
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. [2006.10.15]
Continuous femoral nerve block versus intra-articular injection for pain control after anterior cruciate ligament reconstruction. [2006.08]
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. [2006.03]
Evaluation of a single-dose, extended-release epidural morphine formulation for pain after knee arthroplasty. [2006.02]
Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. [2006]
Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial. [2005.12]
A prospective, randomized, double-blind study evaluating the efficacy of postoperative continuous local anesthetic infusion at the iliac crest bone graft site after spinal arthrodesis. [2005.11.15]
The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery. [2005.10]
The effects of femoral nerve blockade in conjunction with epidural analgesia after total knee arthroplasty. [2005.09]
Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial. [2005.09]
Acetaminophen decreases early post-thoracotomy ipsilateral shoulder pain in patients with thoracic epidural analgesia: a double-blind placebo-controlled study. [2005.08]
Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy. [2005.08]
Comparison of perioperative analgesic protocols for dogs undergoing tibial plateau leveling osteotomy. [2005.07]
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. [2005.03]
The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. [2005.02.17]
Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. [2005.01]
|
